vs
AVANOS MEDICAL, INC.（AVNS）与MSA Safety Inc（MSA）财务数据对比。点击上方公司名可切换其他公司
MSA Safety Inc的季度营收约是AVANOS MEDICAL, INC.的2.8倍（$510.9M vs $180.9M）。MSA Safety Inc净利率更高（17.0% vs -0.7%，领先17.7%）。MSA Safety Inc同比增速更快（2.2% vs 0.7%）。MSA Safety Inc自由现金流更多（$106.0M vs $21.3M）。过去两年MSA Safety Inc的营收复合增速更高（11.2% vs 4.4%）
Avanos Medical是一家医疗科技企业，专注于研发生产临床医疗设备，核心业务围绕疼痛管理与慢性护理两大板块展开，致力于帮助患者加快康复、预防感染，同时减少临床治疗中阿片类药物的使用。
MSA安全是美国专业安全设备生产供应商，面向建筑、军事、消防、化工、油气等存在高危作业场景的多个行业提供安全防护产品及解决方案，总部位于美国匹兹堡近郊的克兰伯里。
AVNS vs MSA — 直观对比
营收规模更大
MSA
是对方的2.8倍
$180.9M
营收增速更快
MSA
高出1.5%
0.7%
净利率更高
MSA
高出17.7%
-0.7%
自由现金流更多
MSA
多$84.7M
$21.3M
两年增速更快
MSA
近两年复合增速
4.4%
损益表 — Q4 2025 vs Q4 2025
| 指标 | | |
|---|---|---|
| 营收 | $180.9M | $510.9M |
| 净利润 | $-1.3M | $86.9M |
| 毛利率 | 47.5% | 46.9% |
| 营业利润率 | 1.4% | 22.3% |
| 净利率 | -0.7% | 17.0% |
| 营收同比 | 0.7% | 2.2% |
| 净利润同比 | 99.7% | -1.2% |
| 每股收益（稀释后） | $-0.02 | $2.22 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收AVNSMSA
| Q4 25 | $180.9M | $510.9M | ||
| Q3 25 | $177.8M | $468.4M | ||
| Q2 25 | $175.0M | $474.1M | ||
| Q1 25 | $167.5M | $421.3M | ||
| Q4 24 | $179.6M | $499.7M | ||
| Q3 24 | $170.4M | $432.7M | ||
| Q2 24 | $171.7M | $462.5M | ||
| Q1 24 | $166.1M | $413.3M |
净利润AVNSMSA
| Q4 25 | $-1.3M | $86.9M | ||
| Q3 25 | $-1.4M | $69.6M | ||
| Q2 25 | $-76.8M | $62.8M | ||
| Q1 25 | $6.6M | $59.6M | ||
| Q4 24 | $-397.3M | $87.9M | ||
| Q3 24 | $4.3M | $66.6M | ||
| Q2 24 | $1.8M | $72.2M | ||
| Q1 24 | $-900.0K | $58.1M |
毛利率AVNSMSA
| Q4 25 | 47.5% | 46.9% | ||
| Q3 25 | 48.4% | 46.5% | ||
| Q2 25 | 52.6% | 46.6% | ||
| Q1 25 | 53.6% | 45.9% | ||
| Q4 24 | 54.6% | 46.9% | ||
| Q3 24 | 54.5% | 47.9% | ||
| Q2 24 | 55.7% | 48.2% | ||
| Q1 24 | 57.1% | 47.3% |
营业利润率AVNSMSA
| Q4 25 | 1.4% | 22.3% | ||
| Q3 25 | 0.1% | 20.1% | ||
| Q2 25 | -42.6% | 18.1% | ||
| Q1 25 | 6.1% | 18.5% | ||
| Q4 24 | -233.0% | 23.5% | ||
| Q3 24 | 7.0% | 21.1% | ||
| Q2 24 | 3.7% | 21.6% | ||
| Q1 24 | 2.4% | 19.4% |
净利率AVNSMSA
| Q4 25 | -0.7% | 17.0% | ||
| Q3 25 | -0.8% | 14.9% | ||
| Q2 25 | -43.9% | 13.2% | ||
| Q1 25 | 3.9% | 14.1% | ||
| Q4 24 | -221.2% | 17.6% | ||
| Q3 24 | 2.5% | 15.4% | ||
| Q2 24 | 1.0% | 15.6% | ||
| Q1 24 | -0.5% | 14.1% |
每股收益（稀释后）AVNSMSA
| Q4 25 | $-0.02 | $2.22 | ||
| Q3 25 | $-0.03 | $1.77 | ||
| Q2 25 | $-1.66 | $1.59 | ||
| Q1 25 | $0.14 | $1.51 | ||
| Q4 24 | $-8.64 | $2.22 | ||
| Q3 24 | $0.09 | $1.69 | ||
| Q2 24 | $0.04 | $1.83 | ||
| Q1 24 | $-0.02 | $1.47 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $89.8M | $165.1M |
| 总债务越低越好 | $90.3M | $580.9M |
| 股东权益账面价值 | $778.2M | $1.4B |
| 总资产 | $1.1B | $2.6B |
| 负债/权益比越低杠杆越低 | 0.12× | 0.42× |
8季度趋势，按日历期对齐
现金及短期投资AVNSMSA
| Q4 25 | $89.8M | $165.1M | ||
| Q3 25 | $70.5M | $170.0M | ||
| Q2 25 | $90.3M | $147.0M | ||
| Q1 25 | $97.0M | $170.6M | ||
| Q4 24 | $107.7M | $164.6M | ||
| Q3 24 | $89.0M | $154.4M | ||
| Q2 24 | $92.2M | $146.8M | ||
| Q1 24 | $75.8M | $148.3M |
总债务AVNSMSA
| Q4 25 | $90.3M | $580.9M | ||
| Q3 25 | $93.4M | $628.6M | ||
| Q2 25 | $95.7M | $679.3M | ||
| Q1 25 | $98.0M | $502.1M | ||
| Q4 24 | $125.3M | $508.0M | ||
| Q3 24 | $152.6M | $554.7M | ||
| Q2 24 | $164.9M | $588.2M | ||
| Q1 24 | $167.2M | $596.2M |
股东权益AVNSMSA
| Q4 25 | $778.2M | $1.4B | ||
| Q3 25 | $778.0M | $1.3B | ||
| Q2 25 | $776.3M | $1.3B | ||
| Q1 25 | $839.4M | $1.2B | ||
| Q4 24 | $828.5M | $1.1B | ||
| Q3 24 | $1.2B | $1.1B | ||
| Q2 24 | $1.2B | $1.0B | ||
| Q1 24 | $1.2B | $994.8M |
总资产AVNSMSA
| Q4 25 | $1.1B | $2.6B | ||
| Q3 25 | $1.1B | $2.6B | ||
| Q2 25 | $1.0B | $2.6B | ||
| Q1 25 | $1.1B | $2.2B | ||
| Q4 24 | $1.2B | $2.2B | ||
| Q3 24 | $1.7B | $2.2B | ||
| Q2 24 | $1.7B | $2.2B | ||
| Q1 24 | $1.7B | $2.2B |
负债/权益比AVNSMSA
| Q4 25 | 0.12× | 0.42× | ||
| Q3 25 | 0.12× | 0.48× | ||
| Q2 25 | 0.12× | 0.54× | ||
| Q1 25 | 0.12× | 0.42× | ||
| Q4 24 | 0.15× | 0.44× | ||
| Q3 24 | 0.12× | 0.51× | ||
| Q2 24 | 0.13× | 0.57× | ||
| Q1 24 | 0.14× | 0.60× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $28.2M | $122.4M |
| 自由现金流经营现金流 - 资本支出 | $21.3M | $106.0M |
| 自由现金流率自由现金流/营收 | 11.8% | 20.8% |
| 资本支出强度资本支出/营收 | 3.8% | 3.2% |
| 现金转化率经营现金流/净利润 | — | 1.41× |
| 过去12个月自由现金流最近4个季度 | $43.1M | $295.4M |
8季度趋势，按日历期对齐
经营现金流AVNSMSA
| Q4 25 | $28.2M | $122.4M | ||
| Q3 25 | $14.0M | $112.5M | ||
| Q2 25 | $6.8M | $67.2M | ||
| Q1 25 | $25.7M | $61.8M | ||
| Q4 24 | $57.9M | $107.9M | ||
| Q3 24 | $23.0M | $84.3M | ||
| Q2 24 | $27.8M | $53.3M | ||
| Q1 24 | $-8.0M | $50.9M |
自由现金流AVNSMSA
| Q4 25 | $21.3M | $106.0M | ||
| Q3 25 | $7.0M | $100.5M | ||
| Q2 25 | $-4.2M | $37.9M | ||
| Q1 25 | $19.0M | $51.0M | ||
| Q4 24 | $53.1M | $93.5M | ||
| Q3 24 | $20.0M | $70.1M | ||
| Q2 24 | $21.9M | $39.0M | ||
| Q1 24 | $-12.1M | $39.7M |
自由现金流率AVNSMSA
| Q4 25 | 11.8% | 20.8% | ||
| Q3 25 | 3.9% | 21.4% | ||
| Q2 25 | -2.4% | 8.0% | ||
| Q1 25 | 11.3% | 12.1% | ||
| Q4 24 | 29.6% | 18.7% | ||
| Q3 24 | 11.7% | 16.2% | ||
| Q2 24 | 12.8% | 8.4% | ||
| Q1 24 | -7.3% | 9.6% |
资本支出强度AVNSMSA
| Q4 25 | 3.8% | 3.2% | ||
| Q3 25 | 3.9% | 2.6% | ||
| Q2 25 | 6.3% | 6.2% | ||
| Q1 25 | 4.0% | 2.6% | ||
| Q4 24 | 2.7% | 2.9% | ||
| Q3 24 | 1.8% | 3.3% | ||
| Q2 24 | 3.4% | 3.1% | ||
| Q1 24 | 2.5% | 2.7% |
现金转化率AVNSMSA
| Q4 25 | — | 1.41× | ||
| Q3 25 | — | 1.62× | ||
| Q2 25 | — | 1.07× | ||
| Q1 25 | 3.89× | 1.04× | ||
| Q4 24 | — | 1.23× | ||
| Q3 24 | 5.35× | 1.27× | ||
| Q2 24 | 15.44× | 0.74× | ||
| Q1 24 | — | 0.88× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
AVNS
| Enteral Feeding | $83.0M | 46% |
| Radiofrequency Ablation | $36.9M | 20% |
| Neonate Solutions | $32.1M | 18% |
| Surgical Pain And Recovery | $24.7M | 14% |
| Corporate Other | $4.2M | 2% |
MSA
| Americas Segment | $335.2M | 66% |
| International Segment | $175.7M | 34% |
